United Kingdom· GB-APID-42527511000001100
Livmarli 9.5mg/ml oral solution
A medicinal product containing maralixibat, registered in United Kingdom by Mirum Pharmaceuticals International BV.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Maralixibat
- Manufacturer
- Mirum Pharmaceuticals International BV
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Maralixibat in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaLIVMARLIMIRUM PHARMACEUTICALS, INC.
- BelgiumLivmarli 10 mgMirum Pharmaceuticals International
- CzechiaLIVMARLIMirum Pharmaceuticals International B.V., Amsterdam
- FinlandLivmarliMirum Pharmaceuticals International B.V.
- IrelandLivmarli 10 mg tabletsMirum Pharmaceuticals International B.V.
- IcelandLivmarliMirum Pharmaceuticals International B.V.
- SwedenLivmarli 10 mg TablettMirum Pharmaceuticals International B.V.
- United StatesLivmarliMirum Pharmaceuticals Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Livmarli
- Liechtenstein · Livmarli
- Norway · Livmarli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f115350f-3b8a-402f-bb08-a0e68303ac02 GET /v1/drugs/f115350f-3b8a-402f-bb08-a0e68303ac02?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42527511000001100",
"desc": "Livmarli 9.5mg/ml oral solution (Mirum Pharmaceuticals International BV)",
"form": "Oral solution",
"vpid": "42534511000001106",
"source": "dmd",
"vtm_id": "42534211000001108",
"strength": "9.5 mg",
"substance": "Maralixibat",
"ingredient": "Maralixibat chloride",
"supplier_code": "42438211000001105"
}See everything about maralixibat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.